BioSpace News Archive

SEASUN BIOMATERIALS announced on 1 May that they are about to release their second COVID-19 assay “AQ-TOP COVID-19 Rapid Detection Kit” just after the completion of FDA EUA (April-27) of their U-TOP COVID-19 Real-Time Detection Kit.

What’s New: As part of Intel’s $50 million pandemic response, Intel and Medical Informatics Corp. announced the Scale to Serve Program to help hospitals rapidly install and scale MIC’s Sickbay™ platform.

New Solutions Include Critical Screenings and Longitudinal Monitoring for Patients and Staff as States Reopen and Elective Procedures Resume

PPD, Inc. (Nasdaq: PPD ), a leading global contract research organization, has extended its digital clinical trial solutions to support biopharma companies’ research continuity initiatives and to help ensure patient safety as part of its integrated response to the COVID-19 pandemic. PPD’s extensive, flexible suite of digital trial solutions – from electronic patient consent to telehealth to hybrid and fully dece

To address some of the confusion surrounding COVID-19 testing, AACC launched a video series in which leading laboratory experts answer common questions about tests for the pandemic.

Protein aggregation is a common challenge in the manufacturing of biological products. As one of the most sensitive techniques for the detection of aggregates, dynamic light scattering (DLS) provides a simple, fast and non-destructive testing method.

International working group says the SF3B1 variant identifies a distinct disease entity, should inform WHO guidelines

Montefiore and Albert Einstein College of Medicine Partner with NYU Langone Health to Determine if Blood from COVID-19 Survivors Can Aid Current COVID-19 Patients

Iovance Biotherapeutics, Inc. announced that new interim data from Cohort 2 in the C-144-01 study of lifileucel in advanced melanoma will be provided as an oral presentation at the American Society of Clinical Oncology’s upcoming ASCO20 Virtual Scientific Program, to be held May 29-31, 2020.

PhotoPharmics, a pioneer in specialized phototherapy, today announced that it has received FDA Breakthrough device designation for the company’s non-invasive, in-home device for treating Parkinson’s Disease.